{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T01:20:04Z","timestamp":1768180804471,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Angiogenesis is critical for the development, progression, and metastasis of hepatocellular carcinoma (HCC), but the roles of miR\u20103064\u20105p in HCC angiogenesis are still unknown. In this study, the roles of miR\u20103064\u20105p in HCC angiogenesis were studied in 192 HCC patients, xenograft mouse models, and HCC cell lines. The results showed that miR\u20103064\u20105p expression was significantly decreased in HCC tissues and cells, and downregulated miR\u20103064\u20105p was associated with upregulated angiogenic potential of HCC. MiR\u20103064\u20105p inhibited proangiogenic VEGFA and angiogenin expressions but induced antiangiogenic endostatin and MMP12 expressions, finally leading to suppression of HCC angiogenesis, as shown by the decline in intratumoral microvessel density (MVD). Moreover, miR\u20103064\u20105p was inversely correlated with lncRNA MALAT1 and FOXA1. FOXA1 bound to and interacted with CD24 and then regulated Src phosphorylation. MiR\u20103064\u20105p played an antiangiogenic role by inhibiting the FOXA1\/CD24\/Src pathway, whereas oncogenic MALAT1 functioned as a competing endogenous RNA (ceRNA) by sponging miR\u20103064\u20105p to alleviate the suppressive effect on the FOXA1 pathway. HCC patients with high miR\u20103064\u20105p, low MALAT1, or low FOXA1 expression had a better prognosis with longer overall survival and recurrence\u2010free survival. In univariate and multivariate analyses, miR\u20103064\u20105p was identified as the independent prognostic predicator for HCC progression and patient survival. Taken together, miR\u20103064\u20105p exerts an antiangiogenic role by targeting the FOXA1\/CD24\/Src pathway but oncogenic lncRNA MALAT1 acts as a ceRNA to sponge miR\u20103064\u20105p. MiR\u20103064\u20105p is of great clinical significance and is a novel prognostic indicator and an attractive therapeutic target for HCC.<\/jats:p>","DOI":"10.1096\/fj.201901834r","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T04:22:45Z","timestamp":1573791765000},"page":"66-81","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["MicroRNA\u20103064\u20105p sponged by MALAT1 suppresses angiogenesis in human hepatocellular carcinoma by targeting the FOXA1\/CD24\/Src pathway"],"prefix":"10.1096","volume":"34","author":[{"given":"Pei","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Ha","sequence":"additional","affiliation":[{"name":"School of Nursing Chongqing Medical and Pharmaceutical College Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianbing","family":"Li","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Birth Defects and Reproductive Health Chongqing Population and Family Planning Science and Technology Research Institute Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Birth Defects and Reproductive Health Chongqing Population and Family Planning Science and Technology Research Institute Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changjiang","family":"Liu","sequence":"additional","affiliation":[{"name":"NHC Key Laboratory of Birth Defects and Reproductive Health Chongqing Population and Family Planning Science and Technology Research Institute Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,11,15]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyr016"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35786-6"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-017-0017-y"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.01.049"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0851"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0978-y"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-015-0182-1"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.321646"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26941"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20859-3"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.356"},{"key":"e_1_2_9_13_1","first-page":"5273","article-title":"The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas","volume":"62","author":"Lin L","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3155"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-1882"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.11.026"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3916"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0151"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00181"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-011-0756-9"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-011-9426-4"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1055-9"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000071841.17900.69"},{"key":"e_1_2_9_24_1","first-page":"4852","article-title":"Increased expression of angiogenin in hepatocellular carcinoma in correlation with tumor vascularity","volume":"9","author":"Hisai H","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_9_25_1","first-page":"45","article-title":"Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas","volume":"61","author":"Musso O","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205859"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0463-1"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2931"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.12.049"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-1508"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.278"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.201901834R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.201901834R","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.201901834R","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:48:57Z","timestamp":1761677337000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.201901834R"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1096\/fj.201901834R"],"URL":"https:\/\/doi.org\/10.1096\/fj.201901834r","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,15]]},"assertion":[{"value":"2019-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}